HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Online-Only Appendix All Versions of this Article: dc07-0147v1 30/8/2086    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaidya, D. Articles by Ouyang, P. Search for Related Content PubMed PubMed Citation Articles by Vaidya, D. Articles by Ouyang, P. Social Bookmarking                What's this?

Defining the Metabolic Syndrome Construct

Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis

¹ Johns Hopkins University, Baltimore, Maryland
² Northwestern University, Chicago, Illinois
³ University of Minnesota, Minneapolis, Minnesota
⁴ Wake Forest University, Winston-Salem, North Carolina

Address correspondence and reprint requests to Dhananjay Vaidya, PhD, Johns Hopkins Medical Institutions, 1830 E. Monument St., Suite 8028-A, Baltimore, MD 21287. E-mail: dvaidya1{at}jhmi.edu

OBJECTIVE—It is controversial whether the clustering of certain metabolic abnormalities should be separately designated as the metabolic syndrome. We operationalized the "syndrome" concept and tested whether the metabolic syndrome was compatible with these operational constructs.

RESEARCH DESIGN AND METHODS—The baseline cross-section of the Multi-Ethnic Study of Atherosclerosis recruited a population-based cohort of 6,781 individuals, aged 45–84 years, from six communities in the U.S. Metabolic syndrome components (waist circumference, blood pressure, fasting serum HDL cholesterol, triglycerides, and plasma glucose), homeostasis model assessment (HOMA) of insulin resistance (fasting glucose x insulin), and intimal-medial thickness (IMT) in the common and internal carotid arteries by B-mode ultrasound were measured.

RESULTS—Higher syndrome component count is associated with higher HOMA levels (trend P < 0.001). Given the prevalence of individual components, the nonprevalence of any component or the co-prevalence of four or five components is greater than expected (² P < 0.001). After accounting for the additive association of each component, the current definition of metabolic syndrome (co-prevalence of three or more components) does not have supra-additive association with thicker IMT in the common carotid (men: P = 0.075, women: P = 0.949) or internal carotid artery (men: P = 0.106, women: P = 0.121).

CONCLUSIONS—The metabolic syndrome did not have supra-additive association with IMT, but its components clustered greater than chance expectation and a higher component count was associated with greater insulin resistance. The metabolic syndrome was compatible with two of three "syndrome" constructs tested.

Abbreviations: CIMT, common carotid artery intimal-medial thickness • HOMA, homeostasis model assessment • IIMT, internal carotid artery intimal-medial thickness • IMT, intimal-medial thickness • MESA, Multi-Ethnic Study of Atherosclerosis

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K G M M Alberti and P Z Zimmet Should we dump the metabolic syndrome? No BMJ, March 22, 2008; 336(7645): 641 - 641. [Full Text] [PDF]